Opioid prescription for terminally ill outpatients in a district of northern Italy: A retrospective survey

Pharmacological Research

Volumn 48, Issue 1, 2003, Pages 75-82

  Salvato, Chiara ^a   Aretini, Gianfranco ^a   Serraglia, Donatella ^a   Terrazzani, Gianni ^a   Debetto, Patrizia ^b   Giusti, Pietro ^b   Chinellato, Alessandro ^a  

^a Local Health Authority ULSS 9   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cancer pain management; Morphine; Opioid prescribing attitudes; Opioid use

Indexed keywords

BUPRENORPHINE; MORPHINE; PENTAZOCINE;

ADULT; ARTICLE; CANCER PAIN; CANCER PATIENT; CONSTIPATION; CONTROLLED STUDY; EVALUATION; FEMALE; GENERAL PRACTITIONER; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIDE EFFECT; TERMINALLY ILL PATIENT; WORLD HEALTH ORGANIZATION;

EID: 0038288984     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00060-4     Document Type: Article

References (33)

1. Cleeland C.S., Gonin R., Hatfield A.K., Edmonson J.H., Blum R.H., Stewart J.A.et al. Pain and its treatment in outpatients with metastatic cancer. New Engl. J. Med. 330:1994;592-596.
2. Larue F., Colleau S.M., Brasseur L., Cleeland C.S. Multicentre study of cancer pain and its treatment in France. Br. Med. J. 310:1995;1034-1037.
3. Weiss S.C., Emanuel L.L., Fairclough D.L., Emanuel E.J. Understanding the experience of pain in terminally ill patients. Lancet. 357:2001;1311-1315.
4. World Health Organization. Cancer pain relief and palliative care. Report of a WHO expert committee. Technical Report Series 804. Geneva. 1990. p. 7-18.
5. World Health Organization. Cancer pain relief, 2nd ed., with a guide to opioid availability. Geneva. 1996.
6. Zech D.F.J., Grond S., Lynch J., Hertel D., Lehmann K.A. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 63:1995;65-76.
7. Levy M.H. Pharmacologic treatment of cancer pain. New Engl. J. Med. 335:1996;1124-1132.
8. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer. 85:1999;1849-1858.
9. Mercadante S. Oral morphine consumption in Italy and Sicily. J. Pain Symptom Manage. 15:1998;227-230.
10. Mayor S. Survey of patients shows that cancer pain still undertreated. Br. Med. J. 321:2000;1309.
11. Bauwens S., Distelmans W., Storme G., Kaufman L. Attitudes and knowledge about cancer pain in Flanders. The educational effect of workshops regarding pain and symptom control. Palliat. Med. 15:2001;181-189.
12. Pearl J.D. Cancer pain management: still a public health issue. Am. Soc. Anesth. Newslett. 62:1998;18-20.
13. McCaffery M. Pain control. Barriers to the use of available information. World Health Organization Expert Committee on Cancer Pain Relief and Active Supportive Care. Cancer. 70:1992;1438-1449.
14. Mercadante S., Salvaggio L. Cancer pain knowledge in southern Italy: data from a postgraduate refresher course. J. Pain Symptom Manage. 11:1996;108-115.
15. Ger L.P., Ho S.T., Wang J.J. Physicians' knowledge and attitudes toward the use of analgesics for cancer pain management: a survey of two medical centers in Taiwan. J. Pain Symptom Manage. 20:2000;335-344.
16. Rajagopal M.R., Joranson D.E., Gilson A.M. Medical use, misuse, and diversion of opioids in India. Lancet. 358:2001;139-143.
17. Vanegas G., Ripamonti C., Sbanotto A., De Conno F. Side effects of morphine administration in cancer patients. Cancer Nurs. 21:1998;289-297.
18. Vainio A. Treatment of terminal cancer pain in France: a questionnaire study. Pain. 62:1995;155-162.
19. Vainio A. Use of morphine and other opioids in the Nordic countries. Acta Oncol. 37:1998;743-748.
20. Fujimoto D. Regulatory issues in pain management. Clin. Geriatr. Med. 17:2001;537-551.
21. Garcia del Pozo J., Carvajal A., Rueda de Castro A.M., Cano del Pozo M.I., Martin Arias L.H. Opioid consumption in Spain - the significance of a regulatory measure. Eur. J. Clin. Pharmacol. 55:1999;681-683.
22. International Narcotics Control Board (INCB). Report for 2000. United Nations, New York. 2001.
23. Legge 8 febbraio 2001, n. 12. "Norme per agevolare l'impiego dei farmaci analgesici oppiacei nella terapia del dolore". Gazzetta Ufficiale n. 41. 19 febbraio 2001.
24. Mercadante S., Fulfaro F., Casuccio A. Pattern of drug use by advanced cancer patients followed at home. J. Palliat. Care. 17:2001;37-40.
25. Minotti V., Betti M. Attitudes of Italian general practitioners in the treatment of cancer pain. Tumori. 83:1997;729-731.
26. Boffi R., Caraceni A., Portenoy R., Andersen H., Lonati G., De Conno F. Attitudine di diverse categorie di medici italiani verso gli oppioidi. Rivista Italiana di Cure Palliative. 3:2001;209-215.
27. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo. 2000.
28. Ronning M., Blix H.S., Harbo B.T., Strom H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose - are drug utilization data comparable? Eur. J. Clin. Pharmacol. 56:2000;723-727.
29. Simonato L, Zambon P, Guzzinati S, Tognazzo S, Bertolin I, Stocco CF, Fiore AR, Greco A. Incidenza del cancro nella Regione Veneto negli anni 1995-1996. CLEUP, Padova. Dicembre 1999.
30. Billing J.A. Recent advances: palliative care. Br. Med. J. 321:2000;555-558.
31. Bernatzky G., Pipam W., Pinter G., Mitterschiffthaler G., Likar R. Opioid therapy in Austria: results and analysis of a survey. Schmerz. 13:1999;266-272.
32. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J.L. Trends in medical use and abuse of opioid analgesics. J. Am. Med. Assoc. 283:2000;1710-1714.
33. Lamberg L. Patients in pain need round-the-clock care. J. Am. Med. Assoc. 281:1999;689-690.